Literature DB >> 8964844

Type II and type III deiodinase activity in human placenta as a function of gestational age.

J M Koopdonk-Kool1, J J de Vijlder, G J Veenboer, C Ris-Stalpers, J H Kok, T Vulsma, K Boer, T J Visser.   

Abstract

Thyroid hormones are essential for fetal development. T4 can be activated by type I (ID-I) and type II (ID-II) iodothyronine deiodinase or inactivated by type III deiodinase (ID-III). The influence of placental ID-II and ID-III on the regulation of fetal thyroid hormone levels was investigated. Using [125I]T4 and [125I]T3, respectively, ID-II and ID-III activities were measured in homogenates of normal human placentas from 6-43 weeks gestational age and in placentas from five term neonates with a total thyroid hormone synthesis defect. ID-II and ID-III activities related to protein or DNA concentration decreased and total placental ID-III activity increased significantly during pregnancy, whereas the increase in total placental ID-II activity was not significant. Absolute placental ID-II activity was approximately 200 times lower than ID-III activity at all gestational ages. Therefore, fluctuations in ID-II activity were not likely to have a significant influence on fetal thyroid hormone concentrations, but may play a role in the regulation of intraplacental T3 generation. The high ID-III activity most likely influences the thyroid hormone economy of the fetus. Severely hypothyroid newborns showed strongly decreased serum T4 levels, but serum T3 and placental ID-III activities were similar to those in euthyroid newborns. These results suggest that placental ID-III activity is regulated by serum T3, but not by serum T4.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8964844     DOI: 10.1210/jcem.81.6.8964844

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  24 in total

1.  Pregnant rat uterus expresses high levels of the type 3 iodothyronine deiodinase.

Authors:  V A Galton; E Martinez; A Hernandez; E A St Germain; J M Bates; D L St Germain
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 2.  The selenoenzyme family of deiodinase isozymes controls local thyroid hormone availability.

Authors:  J Köhrle
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

Review 3.  Action of thyroid hormone in brain.

Authors:  J Bernal
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

Review 4.  The role of the placenta in thyroid hormone delivery to the fetus.

Authors:  Shiao Y Chan; Elisavet Vasilopoulou; Mark D Kilby
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

5.  Type 3 deiodinase is critical for the maturation and function of the thyroid axis.

Authors:  Arturo Hernandez; M Elena Martinez; Steven Fiering; Valerie Anne Galton; Donald St Germain
Journal:  J Clin Invest       Date:  2006-01-12       Impact factor: 14.808

Review 6.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

7.  Imprinting analysis of porcine DIO3 gene in two fetal stages and association analysis with carcass and meat quality traits.

Authors:  Mu Qiao; Hua-Yu Wu; Ling Guo; Shu-Qi Mei; Peng-Peng Zhang; Feng-E Li; Rong Zheng; Chang-Yan Deng
Journal:  Mol Biol Rep       Date:  2011-06-10       Impact factor: 2.316

Review 8.  Antithyroid drug-induced fetal goitrous hypothyroidism.

Authors:  Sofie Bliddal; Ase Krogh Rasmussen; Karin Sundberg; Vibeke Brocks; Ulla Feldt-Rasmussen
Journal:  Nat Rev Endocrinol       Date:  2011-03-15       Impact factor: 43.330

9.  Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10.

Authors:  Edith C H Friesema; Jurgen Jansen; Jan-Willem Jachtenberg; W Edward Visser; Monique H A Kester; Theo J Visser
Journal:  Mol Endocrinol       Date:  2008-03-12

10.  Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.

Authors:  S-Y Chan; J A Franklyn; H N Pemberton; J N Bulmer; T J Visser; C J McCabe; M D Kilby
Journal:  J Endocrinol       Date:  2006-06       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.